Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析

◆英語タイトル:Noranda Income Fund (NIF.UN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1491
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥14,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Noranda Income Fund (NIF.UN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Noranda Income Fund (NIF) is an open-ended trust. It owns the electrolytic zing processing facility and ancillary assets located in Qubec. It produces refined zinc metal and different by-products from sourced zinc concentration. Its processing facility is operated and administrated by Canadian Electrolytic Zinc Limited, a wholly owned subsidiary of Glencore Canada Corporation. The fund offers Jumbo Zinc, Zinc shot, and granulated zinc and its by-products include sulphuric acid. It has operations in Canada and the US. NIF is headquartered in Toronto, Canada.

Noranda Income Fund Key Recent Developments

Apr 02,2020 Noranda Income Fund announces COVID-19 business update
Mar 12,2020 Noranda Income Fund reports terms for 2020/2021 contractual period
Feb 25,2020 Noranda Income Fund posts Q4 and full year 2019 results
Dec 19,2019 Noranda Income Fund announces special cash distribution of 2019 taxable income

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Noranda Income Fund – Key Facts
Noranda Income Fund – Key Employees
Noranda Income Fund – Key Employee Biographies
Noranda Income Fund – Major Products and Services
Noranda Income Fund – History
Noranda Income Fund – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Noranda Income Fund – Business Description
Noranda Income Fund – SWOT Analysis
SWOT Analysis – Overview
Noranda Income Fund – Strengths
Noranda Income Fund – Weaknesses
Noranda Income Fund – Opportunities
Noranda Income Fund – Threats
Noranda Income Fund – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Apr 02, 2020: Noranda Income Fund announces COVID-19 business update
Mar 12, 2020: Noranda Income Fund reports terms for 2020/2021 contractual period
Feb 25, 2020: Noranda Income Fund posts Q4 and full year 2019 results
Dec 19, 2019: Noranda Income Fund announces special cash distribution of 2019 taxable income
Nov 07, 2019: Noranda Income Fund posts Q3 2019 results
Jul 22, 2019: Noranda Income Fund reports second quarter 2019 financial results
Mar 26, 2019: Noranda Income Fund Announces Management Changes
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Noranda Income Fund, Key Facts
Noranda Income Fund, Key Employees
Noranda Income Fund, Key Employee Biographies
Noranda Income Fund, Major Products and Services
Noranda Income Fund, History
Noranda Income Fund, Subsidiaries
Noranda Income Fund, Key Competitors
Noranda Income Fund, Ratios based on current share price
Noranda Income Fund, Annual Ratios
Noranda Income Fund, Annual Ratios (Cont...1)
Noranda Income Fund, Annual Ratios (Cont...2)
Noranda Income Fund, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Noranda Income Fund, Performance Chart (2015 - 2019)
Noranda Income Fund, Ratio Charts

★海外企業調査レポート[Noranda Income Fund (NIF.UN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ADx NeuroSciences NV:企業の製品パイプライン分析2018
    Summary ADx NeuroSciences NV (ADx NeuroSciences) is a medical device company that develops proprietary biomarkers for various neurodegenerative diseases. The company offers biomarkers for Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. It also develops and commercializes analyti …
  • Novant Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Novant Health Inc (Novant Health) is a not-for-profit, integrated healthcare service provider. The organization provides services related to assisted living, blood services, breast health, children’s services, laboratory services, emergency, laboratory services, cancer, urgent care, hospice …
  • Pendopharm-製薬・医療分野:企業M&A・提携分析
    Summary PendoPharm is a healthcare company that offers production and commercialization of a wide range of drugs. The company’s products comprise spans prescription drugs, over-the-counter and behind-the-counter products. Its prescription products offers drugs for therapeutic areas of gastroenterolo …
  • Bioverativ Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • Shikoku Electric Power Co., Inc.:企業の戦略・SWOT・財務分析
    Shikoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Shikoku Electric Power Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Acorda Therapeutics, Inc.:企業の戦略・SWOT・財務情報
    Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acorda Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Canary Wharf Group Plc:企業の戦略・SWOT・財務情報
    Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report Summary Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Singapore Airlines Ltd:企業の戦略・SWOT・財務分析
    Singapore Airlines Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Airlines Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ARMZ Uranium Holding Co:企業の戦略的SWOT分析
    ARMZ Uranium Holding Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Achema AB:企業の戦略的SWOT分析
    Achema AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Uniper SE (UN01):電力:M&Aディール及び事業提携情報
    Summary Uniper SE (Uniper) is an energy utility service provider. The company generates electricity primarily through coal, hydro, oil and gas sources. It offers commodity trading services for power, natural gas, emission certificates, liquefied natural gas, coal and freight. Uniper also provides th …
  • Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft:企業の戦略・SWOT・財務情報
    Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary Munchener Ruckversicherungs-Gesellschaft Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers th …
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Medicure Inc (MPH):企業の財務・戦略的SWOT分析
    Summary Medicure Inc (Medicure) is a pharmaceutical company that strives to research, develop and commercialize therapeutics for cardiovascular diseases. The company offers products such as Aggrastat, a glycoprotein GP IIb/IIIa receptor antagonist indicated for the treatment of acute coronary syndro …
  • China National Offshore Oil Corp:企業の戦略的SWOT分析
    China National Offshore Oil Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報
    Summary Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is …
  • OFG Bancorp (OFG):企業の財務・戦略的SWOT分析
    Summary OFG Bancorp (OFG) operates as a financial service provider that offers banking, treasury, and financial products and services. The company’s consumer banking and lending products comprise residential mortgages, consumer finance, auto loans, and credit cards. Its commercial banking products a …
  • Solco Biomedical Co Ltd (043100):医療機器:M&Aディール及び事業提携情報
    Summary Solco Biomedical Co Ltd (Solco) is a medical device company that manufactures surgical instruments. The company develops and produces implants for orthopedics, neurosurgery, surgical instruments and home functional health products. Its surgical instruments comprise forceps, scissors, needle …
  • 88 Energy Ltd (88E):石油・ガス:M&Aディール及び事業提携情報
    Summary 88 Energy Ltd (88 Energy), formerly Tangiers Petroleum Ltd, is an exploration and production company that develops oil-rich provinces. The company offers discovery, exploration and development of onshore oil projects. It has oil and gas assets in Morocco and Australia. 88 Energy’s Morocco pr …
  • Meril Life Sciences Pvt Ltd:製品パイプライン分析
    Summary Meril Life Sciences Pvt Ltd (Meril) is a medical device company that develops and designs clinically relevant devices. The company’s product categories include cardiovascular devices, vascular interventional devices, orthopedic devices, in-vitro diagnostics devices and endo-surgery devices. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆